A medication requiring hepatic metabolism is not automatically a toxin, and the metabolic pathway differs according to the compound, dose, genetics, nutrition, liver function and drug interactions
2), which can be active in reducing inactive or active forms of vitamin B12
In the body, IGF-1 can activate growth a multitude of bodily tissues, including the nerves, bone, kidneys, and liver
It is effective against senescent cancer cells induced by doxorubicin and cisplatin, highlighting its potential as a senolytic drug
References to obesity, adipose tissue, mitochondrial function, or glucose-related pathways on this page are provided for laboratory research context only